Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Di

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2022
Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScoreCynthuja Thilakanathan, Tahrima Kayes, Julia Di Girolamo, et al.
Canadian Journal of Gastroenterology & Hepatology|October 24, 2022
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?David Stephen Prince, Julia Di Girolamo, Joseph Louis Pipicella, et al.
World Journal of Oncology|November 18, 2017
Poor Accrual in Palliative Research Studies: An Update From the Rapid Response Radiotherapy ProgramKaren Lien, Liang Zeng, Nicole Bradley, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2022
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infectionTahrima Kayes, Harry Crane, Allison Symonds, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Antiviral Therapy|March 31, 2011
Successful efavirenz dose reduction guided by therapeutic drug monitoringAurélie Fayet Mello, Thierry Buclin, Laurent A Decosterd, et al.
The Journal of Infectious Diseases|February 4, 2011
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort studyRubin Lubomirov, Sara Colombo, Julia di Iulio, et al.
Future Virology|December 11, 2023
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE studySambhavi Subramanian, Gretja Schnell, Julia di Iulio, et al.
Molecular Cell|September 15, 2019
Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-DifferentiationAlessandra Dall'Agnese, Luca Caputo, Chiara Nicoletti, et al.
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|July 21, 2022
Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScoreCynthuja Thilakanathan, Tahrima Kayes, Julia Di Girolamo, et al.
Canadian Journal of Gastroenterology & Hepatology|October 24, 2022
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?David Stephen Prince, Julia Di Girolamo, Joseph Louis Pipicella, et al.
World Journal of Oncology|November 18, 2017
Poor Accrual in Palliative Research Studies: An Update From the Rapid Response Radiotherapy ProgramKaren Lien, Liang Zeng, Nicole Bradley, et al.
Alimentary Pharmacology & Therapeutics|May 23, 2022
Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infectionTahrima Kayes, Harry Crane, Allison Symonds, et al.
Antimicrobial Agents and Chemotherapy|September 9, 2010
Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteersMichael Neely, Laurent Decosterd, Aurélie Fayet, et al.
Antiviral Therapy|March 31, 2011
Successful efavirenz dose reduction guided by therapeutic drug monitoringAurélie Fayet Mello, Thierry Buclin, Laurent A Decosterd, et al.
The Journal of Infectious Diseases|February 4, 2011
Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort studyRubin Lubomirov, Sara Colombo, Julia di Iulio, et al.
Future Virology|December 11, 2023
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE studySambhavi Subramanian, Gretja Schnell, Julia di Iulio, et al.
Molecular Cell|September 15, 2019
Transcription Factor-Directed Re-wiring of Chromatin Architecture for Somatic Cell Nuclear Reprogramming toward trans-DifferentiationAlessandra Dall'Agnese, Luca Caputo, Chiara Nicoletti, et al.
Pharmacogenetics and Genomics|February 25, 2009
In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 functionJulia di Iulio, Aurélie Fayet, Mona Arab-Alameddine, et al.
Pageof 9